Urethral Stricture
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
City TherapeuticsUroflowmetry with URI Calculation
Verona PharmaNANOfat grafting
Clinical Trials (2)
Total enrollment: 25 patients across 2 trials
Urethral Resistive Index (URI): A New Parameter for Diagnosing Urethral Obstruction
Start: Feb 2026Est. completion: Jul 2026
N/ANot Yet Recruiting
The Nanofat Regenerative Surgery for Management of Genital Lichen Sclerosus in Male and Female Patients
Start: Jul 2022Est. completion: Jan 202325 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space